SCHEMBL23424044

SCHEMBL23424044

CN1CCN(c2ccc3nc(-c4ccc5nc(-c6ccc(OCCN)cc6)[nH]c5c4)[nH]c3c2)CC1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.80
▸ SMN1; SMN2 Q16637 4/20 0.80
▸ MAPT P10636 3/20 0.80
▸ MEN1 O00255 2/20 0.80
▸ BLM P54132 2/20 0.80
▸ KMT2A Q03164 2/20 0.80
▸ SLCO2B1 O94956 1/20 0.80
▸ GLA P06280 1/20 0.80
▸ RECQL P46063 1/20 0.80
▸ BCL2L1 Q07817 1/20 0.80
▸ SLCO1B3 Q9NPD5 1/20 0.80
▸ TDP1 Q9NUW8 1/20 0.80
▸ SLCO1B1 Q9Y6L6 1/20 0.80
▸ TOP1 P11387 3/20 0.74
▸ TOP2A P11388 3/20 0.74
▸ HPGD P15428 1/20 0.67
▸ HSD17B10 Q99714 1/20 0.67
▸ KDM4E B2RXH2 3/20 0.61
▸ NPC1 O15118 1/20 0.61
▸ POLB P06746 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23424055 0.95 ALDH1A1 (0.78) ALDH1A1SMN1; SMN2MAPTMEN1BLM
SCHEMBL23412226 0.93 ALDH1A1 (0.74) ALDH1A1SMN1; SMN2MAPTMEN1BLM
SCHEMBL14453641 0.91 ALDH1A1 (0.85) ALDH1A1SMN1; SMN2MAPTMEN1BLM
SCHEMBL24299402 0.91 ALDH1A1 (0.71) ALDH1A1SMN1; SMN2MAPTMEN1BLM
SCHEMBL30522159 0.91 ALDH1A1 (0.71) ALDH1A1SMN1; SMN2MAPTMEN1BLM
SCHEMBL38686 0.89 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2MAPTMEN1BLM
SCHEMBL29350649 0.89 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2MAPTMEN1BLM
Hydrochloric Acid SCHEMBL29387917 0.88 ALDH1A1 (0.98) ALDH1A1SMN1; SMN2MAPTMEN1BLM
SCHEMBL14438587 0.87 ALDH1A1 (0.79) ALDH1A1SMN1; SMN2MAPTMEN1BLM
SCHEMBL25434497 0.86 ALDH1A1 (0.77) ALDH1A1SMN1; SMN2MAPTMEN1BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021105887-A1 SEPARATION AND ISOLATION OF NUCLEIC ACIDS USING AFFINITY LIGANDS BOUND TO A SOLID SURFACE EMP BIOTECH GMBH (DE) 2021-06-03 — — WO disclosed
US-20210155657-A1 SEPARATION AND ISOLATION OF NUCLEIC ACIDS USING AFFINITY LIGANDS BOUND TO A SOLID SURFACE EMP BIOTECH GMBH (DE) 2021-05-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210155657-A1 SEPARATION AND ISOLATION OF NUCLEIC ACIDS USING AFFINITY LIGANDS BOUND TO A SOLID SURFACE ADAR, SSBP1, POLRMT ALDH1A1 4165/4885SMN1; SMN2 1103/4885MAPT 4529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback